Underwriters Laboratories
Certified


Quality Systems Regulation
Compliant


CMS Exemplary Provider


Association of Military Surgeons
United States

 


Secure Login



Regenesis Biomedical, Inc.
is a privately held medical technology company focused on developing and marketing noninvasive tissue regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System.

Our customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and outpatient clinics, as well as by patients in their homes by prescription.

We invite you to view our YouTube Channel
You may also follow us on Twitter

Regenesis Biomedical, Inc. is a values-based company dedicated to our stakeholders: Patients, Clinicians, Shareholders, Suppliers and Employees.


Regenesis’ core values include: having a pioneering spirit in the development of new regenerative medical products, striving for excellence in all business aspects, having respect for all people, living and working as a family unified by a common goal, applying integrity in our decision making processes, having compassion for all people, especially our patients, and dedication to improving the lives of all whom we encounter.


For more information:
Regenesis Biomedical, Inc.
1435 N. Hayden Road
Scottsdale, AZ 85257
Toll Free: 877-970-4970
Fax: 866-857-8792


News Wire

Regenesis Biomedical Broadens Board of Directors’ Expertise in Reimbursement

Wound Healing Society Recognizes Scientific Research at Regenesis Biomedical

Patient Satisfaction Remains High at Regenesis Biomedical

Dr. Adrianne (Patti) Smith Promoted to Vice President of Medical Affairs at Regenesis

Regenesis Biomedical Appoints Clinical Research Director

Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer

Regenesis Biomedical to Expand Payor Sources to Increase Patient Access

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference

Inc. Magazine Ranks Regenesis Biomedical as one of America’s Fastest-Growing Companies

Regenesis Biomedical Expands Clinical Resources by Appointing Medical Director

Regenesis Biomedical Announces $5.3 Million in Series C Funding

ISO 13485 Certification Achieved by Regenesis Biomedical

Wound Healing Society Recognizes Scientific Research at Regenesis Biomedical

AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors



Ask for the Yellow Box

 

 

 

 

©2003 - 2012 Copyright Regenesis Biomedical Inc. All Rights Reserved